Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients
Kröger, N, Zabelina, T, Klyuchnikov, E, Kropff, M, Pflüger, K-H, Burchert, A, Stübig, T, Wolschke, C, Ayuk, F, Hildebrandt, Y, Bacher, U, Badbaran, A, Schilling, G, Hansen, T, Atanackovic, D, Zander,Volume:
48
Language:
english
Journal:
Bone Marrow Transplantation
DOI:
10.1038/bmt.2012.142
Date:
March, 2013
File:
PDF, 457 KB
english, 2013